Why Is Arginine the Only Amino Acid That Inhibits Polyglutamine Monomers from Taking on Toxic Conformations?
ACS Chemical Neuroscience · 2024
DOI: 10.1021/acschemneuro.4c00276 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Shoichi Tanimoto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Okazaki 444-8787, Aichi, Japan. Hauptthemen laut MEDLINE: Peptides, Arginine, Molecular Dynamics Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Okazaki 444-8787, Aichi, Japan.
- National Institutes of Natural Sciences, Institute for Molecular Science, Okazaki 444-8787, Aichi, Japan.
- Graduate Institute for Advanced Studies, SOKENDAI, Okazaki 444-8787, Aichi, Japan.
ORCID-Profile: Hisashi Okumura
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tanimoto, S., & Okumura, H. (2024). Why Is Arginine the Only Amino Acid That Inhibits Polyglutamine Monomers from Taking on Toxic Conformations?. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00276
Vancouver
Tanimoto S, Okumura H. Why Is Arginine the Only Amino Acid That Inhibits Polyglutamine Monomers from Taking on Toxic Conformations?. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00276
BibTeX
@article{Tanimoto2024,
author = {Tanimoto, Shoichi and Okumura, Hisashi},
title = {Why Is Arginine the Only Amino Acid That Inhibits Polyglutamine Monomers from Taking on Toxic Conformations?},
journal = {ACS Chemical Neuroscience},
year = {2024},
doi = {10.1021/acschemneuro.4c00276}
}
EUVIMED